Our findings revealed that the KO of Ythdf2 had minimal effects on B16 melanoma tumour growth in immunodeficient hosts, suggesting that the anti‐tumour effect of Ythdf2 KO is T‐cell‐dependent (Figures 3D and S3E). The gene discussed is YTHDF2; the disease is melanoma.